Introduction
Neonatal pneumonia remains a significant contributor to infant mortality worldwide. Identifying infants at high risk for severe disease is challenging because newborns often present with subtle or inconsistent clinical signs. While biomarkers like C-reactive protein (CRP) are commonly used, they often lag behind the inflammatory process. This study investigates whether combining Interleukin-6 (IL-6), an early inflammatory marker, with Urea Nitrogen (UREA), a marker of metabolic stress and renal function, can provide a more accurate "early warning system" for disease severity.
Methods and Patient Population
The researchers conducted a retrospective, cross-sectional analysis of 105 neonates (aged 1–28 days) hospitalized at the Children’s Hospital Affiliated to Zhengzhou University between 2019 and 2022. Patients were categorized into "mild to moderate" (n=76) and "severe" (n=29) pneumonia groups based on clinical guidelines.
Laboratory parameters, including IL-6 (measured via electrochemiluminescence) and UREA (measured via automatic biochemistry analyzer), were collected upon admission. The study excluded infants with confounding conditions such as congenital heart or kidney disease to ensure the biomarkers specifically reflected pneumonia-related stress.
Key Results
The analysis revealed significant differences between the two groups. Both serum IL-6 and UREA levels were markedly higher in the severe pneumonia group compared to the mild-to-moderate group (p < 0.05). Multivariate logistic regression identified IL-6 (OR=1.002) and UREA (OR=1.420) as independent risk factors for pneumonia severity.
The primary finding was the superior predictive performance of the combined model. Receiver Operating Characteristic (ROC) curve analysis showed that the combination of IL-6 and UREA achieved an Area Under the Curve (AUC) of 0.809, significantly outperforming IL-6 (AUC=0.683) or UREA (AUC=0.695) alone.
Optimal cut-off points were determined to be 42.24 pg/mL for IL-6 and 4.05 mmol/L for UREA. Crossing these thresholds, particularly in combination, strongly suggests the presence of severe disease.
Discussion and Clinical Implications
The study supports a "crosstalk" hypothesis between lung inflammation and systemic metabolic stress. Severe pneumonia triggers dehydration and increased protein catabolism, leading to elevated UREA levels even before overt renal failure occurs. Meanwhile, IL-6 acts as a rapid responder in the inflammatory cascade, appearing earlier than other acute-phase proteins.
By combining these two independent markers, clinicians gain a more holistic view of the infant's physiological state. This "biomarker cocktail" offers a sensitive and specific tool for identifying critical cases early, potentially allowing for more aggressive interventions and improved clinical outcomes.
Limitations and Future Work
While promising, the study is limited by its relatively small sample size (N=105) and its single-center, retrospective design. Furthermore, biomarkers were only measured at admission; longitudinal tracking might offer even greater predictive accuracy. Future multi-center studies are needed to validate these findings across diverse populations and explore the long-term outcomes of infants identified through this model.
Summary updated